Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the false negative rate (FNR) associated with Lymphoseek-identified sentinel lymph nodes (SLNs) relative to the pathological status of non-sentinel lymph node...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Navidea Biopharmaceuticals
NCT04080804 · Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT06630780 · Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT06943820 · Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), and more
NCT06673693 · Head and Neck Squamous Cell Carcinoma (HNSCC), HNSCC
NCT05473156 · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), and more
University of Alabama, Birmingham
Birminham, Alabama
Moores UCSD Cancer Center
La Jolla, California
San Diego VA Hospital
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions